|

PF-07799933 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ARRY-440

Pipeline

Phase 1: 2

Top Sponsors

  • Pfizer2

Indications

  • Melanoma2
  • Thyroid Cancer2
  • Glioma2
  • Lung Cancer2
  • Non Small Cell Lung Cancer2

Birmingham, Alabama1 trial

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

The Kirklin Clinic of UAB Hospital

Phase 1

Fayetteville, Arkansas1 trial

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Highlands Oncology Group

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.